EDRIS HOLLAND: Open Payments
NPI 1154929495 · PALMDALE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,869 in 71 payments from 16 companies in 2025. Trend: 2023 $1,083 · 2024 $1,805 · 2025 $1,869
Food & beverage: $1,827Education: $43
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $337 |
| Novo Nordisk Inc | 10 | $252 |
| Regeneron Healthcare Solutions, Inc. | 9 | $235 |
| AstraZeneca Pharmaceuticals LP | 5 | $204 |
| Lilly USA, LLC | 4 | $183 |
| Ardelyx, Inc. | 8 | $173 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $116 |
| Mannkind Corporation | 3 | $94 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $55 |
| Axsome Therapeutics, Inc. | 2 | $53 |
Products named: DUPIXENT, LINZESS, Wegovy, MOUNJARO, IBSRELA, AIRSUPRA, CREON, JOURNAVX.
Industry payments across CA — which companies pay providers there.
